Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality.
作者信息
Carvalho Luiz Sérgio F de, Silva Thiago Quinaglia Ac, Coelho-Filho Otávio Rizzi
机构信息
Disciplina de Cardiologia - Departamento de Medicina Interna - Universidade Estadual de Campinas (UNICAMP), Campinas, SP - Brazil.
Escola Superior de Ciências da Saúde, Brasília, DF - Brazil.
出版信息
Arq Bras Cardiol. 2018 Dec;111(6):808-809. doi: 10.5935/abc.20180226.
Abstract
摘要
相似文献
1
Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality.
Arq Bras Cardiol. 2018 Dec;111(6):808-809. doi: 10.5935/abc.20180226.
2
Cystatin C as a biomarker for estimating glomerular filtration rate.
Curr Opin Nephrol Hypertens. 2015 May;24(3):295-300. doi: 10.1097/MNH.0000000000000115.
3
Cystatin C, vascular biomarkers and measured glomerular filtration rate in patients with unresponsive hypertensive phenotype: a pilot study.
Ren Fail. 2017 Nov;39(1):203-210. doi: 10.1080/0886022X.2016.1256316. Epub 2016 Nov 23.
4
Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients.
Eur J Prev Cardiol. 2016 Oct;23(15):1649-57. doi: 10.1177/2047487316642086. Epub 2016 Apr 1.
5
Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
Eur J Intern Med. 2016 Sep;33:98-101. doi: 10.1016/j.ejim.2016.06.024. Epub 2016 Jun 28.
6
[Glomerular filtration rate estimation and measurement: The quest for precision].
Nephrol Ther. 2018 Apr;14 Suppl 1:S59-S66. doi: 10.1016/j.nephro.2018.02.005.
7
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.
Kidney Int. 2007 Feb;71(3):239-44. doi: 10.1038/sj.ki.5002042. Epub 2006 Dec 20.
8
The Estimation of Glomerular Filtration Rate Based on the Serum Cystatin C and Creatinine Values.
Clin Lab. 2017 Jul 1;63(7):1099-1106. doi: 10.7754/Clin.Lab.2017.161211.
9
[Exploration of renal glomerular function: estimation of glomerular filtration rate].
Nephrol Ther. 2015 Feb;11(1):54-67. doi: 10.1016/j.nephro.2015.01.002. Epub 2015 Feb 14.
10
Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes.
Clin Lab. 2017 Sep 1;63(9):1457-1466. doi: 10.7754/Clin.Lab.2017.170326.
引用本文的文献
1
Adiponectin and TNF-Alpha Differentially Mediate the Association Between Cystatin C and Oxidized LDL in Type 2 Diabetes Mellitus Patients.
Int J Mol Sci. 2025 Mar 25;26(7):3001. doi: 10.3390/ijms26073001.
本文引用的文献
1
Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis.
Arq Bras Cardiol. 2018 Dec;111(6):796-807. doi: 10.5935/abc.20180171. Epub 2018 Sep 21.
2
CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
JACC Cardiovasc Imaging. 2017 Feb;10(2):143-153. doi: 10.1016/j.jcmg.2016.03.022. Epub 2016 Sep 21.
3
Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.
J Am Coll Cardiol. 2016 Aug 30;68(9):934-45. doi: 10.1016/j.jacc.2016.05.092.
4
Quantification of epicardial and intrathoracic fat volume does not provide an added prognostic value as an adjunct to coronary artery calcium score and myocardial perfusion single-photon emission computed tomography.
Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):885-91. doi: 10.1093/ehjci/jev209. Epub 2015 Sep 4.
5
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.
Eur Heart J. 2015 Sep 21;36(36):2446-53. doi: 10.1093/eurheartj/ehv251. Epub 2015 Jun 16.
6
Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration.
Hypertension. 2014 Jun;63(6):1173-81. doi: 10.1161/HYPERTENSIONAHA.113.02683. Epub 2014 Mar 10.
7
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
8
Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Atherosclerosis. 2013 Aug;229(2):541-8. doi: 10.1016/j.atherosclerosis.2013.04.027. Epub 2013 May 3.
9
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Eur Heart J. 2012 May;33(10):1190-200. doi: 10.1093/eurheartj/ehr453. Epub 2012 Mar 8.
10
Cystatin C and contrast-induced acute kidney injury.
Circulation. 2010 May 18;121(19):2117-22. doi: 10.1161/CIRCULATIONAHA.109.919639. Epub 2010 May 3.
Zotero 插件